NIH-funded research R01 grant

Serological and gut virome profiling in type 2 diabetes

Official title: Prospective Study of the Serological Microbial-Viral Interactome and Gut Microbiome-Virome in Type 2 Diabetes

Funded at Brigham and Women's Hospital · NIH-11430219 · Data updated 2026-11-12

A study will map how people with type 2 diabetes respond to gut microbes and their viruses, to see how this interaction relates to diabetes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 15, 2026
Project endMay 31, 2030
Funding year2026
Award (this year)$899,135
NIH project number1R01DK149250-01
Project IDNIH-11430219 on NIH RePORTER

Who could benefit from this research

Could help

Adults with type 2 diabetes or at risk for the condition who participate in stool and blood sample collection.

Less likely to help

People who cannot provide stool or blood samples or who do not meet study criteria may not benefit.

What this research studies

This project will analyze blood antibodies against gut bacteria, viruses, bacteriophages, and fungi, and combine those results with stool DNA data to understand how the gut ecosystem relates to type 2 diabetes. Researchers will use PhIP-Seq to profile antibody responses and integrate these data with metagenomic and metatranscriptomic sequencing from stool samples. Advanced bioinformatics will explore strain-level differences and functional activities in the microbiome and virome to identify links with diabetes progression.

Why it matters

Potential benefit: If successful, the work could reveal new biomarkers and targets for preventing or managing type 2 diabetes through gut-virome interactions.

How similar studies have gone: Prior microbiome studies show associations with diabetes, but this project advances virome and serological profiling for deeper insight.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Wang, Dong — Brigham and Women's Hospital
  • Study coordinator: Wang, Dong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.